Receive CME Credits for the Live Oncofertility Virtual Grand Rounds

After the rounds, complete your evaluation and CME application form to recieve credits.

The next one hour rounds with Kamaljeet Murthy,MD, is at 10 AM Central Time on June 13, 2013: Sexuality After Cancer

 After the Rounds:

Register for Medical Education Credits

 

The Oncofertility Grand Rounds are funded by the NIH (Grant 5UL1DE019587), and an unrestricted educational grant from Ferring Pharmaceuticals, Inc.

Continuing Medical Education Credits:

CME credits will be provided at the Oncofertility Virtual Grand Rounds and is sponsored by the Northwestern University Feinberg School of Medicine.

Accreditation Statement: The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement: The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience: The Oncofertility Virtual Grand Rounds brings together researchers, health care providers, and others together to discuss current updates in fertility preservation and how to incorporate these advances into clinical practice.

Learning Objectives:

  1. Discuss the multiple patient factors that health care providers should understand when treating young fertility preservation patients, including age, legal, ethical, and financial considerations.
  2. Identify key research goals for established and experimental fertility preservation techniques including embryo, oocyte, and ovarian tissue cryopreservation.
  3. Gain an understanding of how select fertility preservation programs ensure a continuum of care between the patient's disease and fertility preservation treatment.
  4. Identify advances in emerging fertility preservation techniques over the past five years and discuss the significance and barriers to implementation in a clinical setting.
  5. Discuss the endocrine, gynecological, psychological, and sexual health considerations for female cancer survivors.

Nursing Contact Hours:

The American Nurses Credentialing Center, American Academy of Nurse Practitioners and American Academy of Physicians Assistants accepts AMA PRA Category 1 Credit(s)™from organizations accredited by the ACCME.

The presenters have no relevant financial relationships with commercial interests that will bias the content of the program.

CME Certificates

In order to obtain your AMA PRA Category 1 Credit(s)™ certificate for this activity, please complete the form below and a link to the evaluation application will be emailed to you at the completion of the live Grand Rounds. Certificates will be emailed to you within 24 hours of completion of the application.

Faculty/Speaker Disclosure Statement and Disclosure for Discussions of OffLabel/Investigational Use of Pharmaceutical Products

In accordance with ACCME Standards for Commercial Support of Continuing Medical Education and the Feinberg School of Medicine’s disclosure policy for CME activities, all individuals who contribute to the content or the identification / resolution of potential conflicts of interest must disclose any relationship they may have with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients within the preceding 12 months of the activity. Such disclosure is intended to provide participants with sufficient information to evaluate whether any given presentation has been influence by the faculty’s relationships(s) or financial interest with said companies. 

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.  The purpose for identifying and addressing potential conflicts of interest is to ensure a proper balance, independence, objectivity and scientific rigor of the medical school’s educational activities. The medical school does not view the existence of a financial relationship as necessarily implying bias or decreasing the value of participation in CME activities, but must ensure that a financial interest is not a conflict of interest.  Identifying Conflict of Interest:  A sixtier peer review system has been developed to identify possible conflicts of interests. 

  • The first tier is the Speaker
  • The secondtier is the Course Director and/or Planning Committee Members
  • The thirdtier is the CME Director
  • The fourthtier is the CME Review Committee
  • The fifthtier is the Senior Associate Dean for Medical Education
  • The sixthtier is the CME Coordinator

FSM’s CME Leadership and Staff:

John X. Thomas, Jr., PhD, Associate Dean for Medical Education - Has nothing to disclose.

Genevieve Napier, CME Director - Has nothing to disclose

Ashley Kick, CME Project Specialist - Has nothing to disclose.

Katy Quinn, CME Project Specialist - Has nothing to disclose.

Tara Scavelli, CME Project Specialist - Has nothing to disclose.

Course Director’s and Planning Committee Members Disclosure Information:

Teresa K. Woodruff, PhD - Has nothing to disclose.

Mary Zelinski, PhD - Has nothing to disclose.

Christos Coutifaris, MD - Serves as a consult for NORA Therapeutics.

Clarisa Gracia, MD - Has nothing to disclose.

Lonnie Shea, PhD - Has nothing to disclose.

Kemi Jona, PhD - Has nothing to disclose.

Richard Stouffer, PhD - Has nothing to disclose.

R. Jeffery Chang, MD - Has nothing to disclose.

Kate Timmerman, PhD - Has nothing to disclose.

Angie Krausfeldt - Has nothing to disclose.

Speakers, Moderators and Panelists’ Disclosure Information:

Zolt Peter Nagy, PhD-Serves as an Advisory Board Member for Origio and received speaker honoraria for MERCK and EMD Serono.

Mary Ellen Pavone has nothing to disclose.

Jennifer Hirshfeld-Cytron has nothing to disclose.

Gregory Dolin, MD, JD, has nothing to disclose.

Cassing Hammond, MD, serves as an IDMC Member of Medicines360, and a Trainer with Merk & Co., Inc

Jessica Kiley, MD, has nothing to disclose.

Clarisa Gracia, MD, MSCE, has nothing to disclose.

Dana Gossett, MD, serves as a Consultant for Bayer Pharmacueticals.

This activity is being sponsored by the Feinberg School of Medicine, Department of Obstetrics and Gynecology  The medical school has no significant relationship with the commercial companies whose products are services are being discussed in this educational activity.